Skip to main navigation Skip to search Skip to main content

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2026), 65, 1, (81-95), 10.1007/s40262-025-01565-6)

  • Q. Zhao
  • , M. M.E. Jongsma
  • , S. A. Vuijk
  • , B. C.M. de Winter
  • , C. Martinez-Vinson
  • , K. L. Kolho
  • , Lorenzo Norsa
  • , S. Hussey
  • , Eytan Wine
  • , Shlomi Cohen
  • , Dror S. Shouval
  • , Amit Assa
  • , R. Lev-Tzion
  • , Tim de Meij
  • , Victorien M. Wolters
  • , Hien Q. Huynh
  • , T. Preijers
  • , L. de Ridder

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2026), 65, 1, (81-95), 10.1007/s40262-025-01565-6)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science